(Q40390236)

English

Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

6

object named as

Gabor Halmos

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

3

object named as

Timo Gaiser

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1

object named as

Gunhild Keller

1 reference

Europe PubMed Central

4 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

author name string

Attila Nagy

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Benjamin Baker

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Clinical Cancer Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

5549-5557

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Gonadotropin-releasing hormone specific binding sites in normal and malignant renal tissue

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Tyrosine kinase inhibitors in renal cell carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Cancer statistics, 2004

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Targeted approaches to cancer therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Gonadotropin-releasing hormone receptor expression in the human prostate

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

A conjugate of doxorubicin and an analog of Luteinizing Hormone-Releasing Hormone shows increased efficacy against oral and laryngeal cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Monoclonal antibody drug immunoconjugates for targeted treatment of cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Renal-cell carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

UICC/CRC conference on targeted cancer therapy. Royal Free Hospital School of Medicine, London, December 17-19, 1991

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Rising incidence of renal cell cancer in the United States

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Inhibition of human hepatocarcinoma cell proliferation by mammalian and fish gonadotropin-releasing hormones

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

An overview of targeted treatments in cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Chemotherapy targeted to cancers through tumoral hormone receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Locally Expressed LHRH Receptors Mediate the Oncostatic and Antimetastatic Activity of LHRH Agonists on Melanoma Cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Membrane receptors for peptides in experimental and human pancreatic cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Effects of luteinising-hormone-releasing hormone on nervous-system tumours.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-04-2464

Identifiers

10.1158/1078-0432.CCR-04-2464

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16061872%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40390236&oldid=2119230450"